BridgeBio Pharma Gets FDA OK For New Drug Application; BBIO Stock Up

BridgeBio Pharma Gets FDA OK For New Drug Application; BBIO Stock Up

BridgeBio Pharma said the FDA accepted its New Drug Application, the first NDA for the company, for its therapy to treat a rare, at times fatal, disease that often targets infants. BBIO rose.